Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhujiang Dai

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cancers|October 14, 2022
Intestinal Microbiota: The Driving Force behind Advances in Cancer ImmunotherapyZhujiang Dai, Jihong Fu, Xiang Peng, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2021
Blocking antibody-mediated phosphatidylserine enhances cancer immunotherapyJie Zhang, Zhujiang Dai, Cheng Yan, et al.
Cell Communication and Signaling : CCS|January 16, 2022
Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancerHuan Zhang, Juan Xing, Zhujiang Dai, et al.
International Journal of Molecular Sciences|April 13, 2023
Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's DiseaseZhujiang Dai, Jie Zhang, Weimin Xu, et al.
World Journal of Surgical Oncology|July 19, 2024
Prognostic significance of negative lymph node count in microsatellite instability-high colorectal cancerXuan Dai, Zhujiang Dai, Jihong Fu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 14, 2021
A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibioticsJie Zhang, Zhujiang Dai, Cheng Yan, et al.
Oncology Research|December 22, 2025
RFX1 Regulates Immune Microenvironment and Predicts Immunotherapy Response in Colon Cancer: A Multi-Omics and Clinical AnalysisZhujiang Dai, Xiaoyong Ge, Wenbo Tang, et al.
Frontiers in Oncology|October 28, 2024
Development and validation of nomograms based on pre-/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resectionXuan Dai, Yifan Li, Haoran Wang, et al.
Cancer Biology & Therapy|June 10, 2024
P4HA2 promotes tumor progression and is transcriptionally regulated by SP1 in colorectal cancerXuening Dang, Xiaojian Chen, Zhonglin Liang, et al.
International Journal of Colorectal Disease|February 13, 2025
Perioperative enhanced recovery program implementation improves clinical outcomes in patients with ulcerative colitis after total proctocolectomy with ileal pouch-anal anastomosisWenjun Ding, Zhujiang Dai, Long Cui, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancers|October 14, 2022
Intestinal Microbiota: The Driving Force behind Advances in Cancer ImmunotherapyZhujiang Dai, Jihong Fu, Xiang Peng, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2021
Blocking antibody-mediated phosphatidylserine enhances cancer immunotherapyJie Zhang, Zhujiang Dai, Cheng Yan, et al.
Cell Communication and Signaling : CCS|January 16, 2022
Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancerHuan Zhang, Juan Xing, Zhujiang Dai, et al.
International Journal of Molecular Sciences|April 13, 2023
Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's DiseaseZhujiang Dai, Jie Zhang, Weimin Xu, et al.
World Journal of Surgical Oncology|July 19, 2024
Prognostic significance of negative lymph node count in microsatellite instability-high colorectal cancerXuan Dai, Zhujiang Dai, Jihong Fu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 14, 2021
A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibioticsJie Zhang, Zhujiang Dai, Cheng Yan, et al.
Oncology Research|December 22, 2025
RFX1 Regulates Immune Microenvironment and Predicts Immunotherapy Response in Colon Cancer: A Multi-Omics and Clinical AnalysisZhujiang Dai, Xiaoyong Ge, Wenbo Tang, et al.
Frontiers in Oncology|October 28, 2024
Development and validation of nomograms based on pre-/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resectionXuan Dai, Yifan Li, Haoran Wang, et al.
Cancer Biology & Therapy|June 10, 2024
P4HA2 promotes tumor progression and is transcriptionally regulated by SP1 in colorectal cancerXuening Dang, Xiaojian Chen, Zhonglin Liang, et al.
International Journal of Colorectal Disease|February 13, 2025
Perioperative enhanced recovery program implementation improves clinical outcomes in patients with ulcerative colitis after total proctocolectomy with ileal pouch-anal anastomosisWenjun Ding, Zhujiang Dai, Long Cui, et al.
Pageof 3